1. López-Chiriboga AS, Majed M, Fryer J, Dubey D, McKeon A, Flanagan EP, Jitprapaikulsan J, Kothapalli N, Tillema JM, Chen J, Weinshenker B, Wingerchuk D, Sagen J, Gadoth A, Lennon VA, Keegan BM, Lucchinetti C, Pittock SJ.Association ofMOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis andProposedDiagnosticCriteriaforMOG-IgG-Associated Disorders.JAMA Neurol. 2018 Nov 1;75(11):1355-1363.
2. Weber MS, Derfuss T, Brück W.Anti-Myelin Oligodendrocyte GlycoproteinAntibody-Associated Central Nervous System Demyelination-A Novel Disease Entity?JAMA Neurol. 2018 Jun 18. [Epub ahead of print]
3. Ramanathan S, Dale RC, Brilot F.Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination.Autoimmun Rev. 2016 Apr;15(4):307-24.
4. Dos Passos GR, Oliveira LM, da Costa BK, Apostolos-Pereira SL, Callegaro D2, Fujihara K, Sato DK.MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder.Front Neurol. 2018 Apr 4;9:217.
5.Reindl M, Di Pauli F, Rostásy K, Berger T.The spectrum of MOG autoantibody-associated demyelinating diseases.Nat Rev Neurol. 2013 Aug;9(8):455-61.
6. Chen L, Chen C, Zhong X, Sun X, Zhu H, Li X, Yang H, Shu Y, Chang Y, Hu X, Lu Z, Peng L, Qiu W.Different features between pediatric-onset and adult-onset patients who are seropositive for MOG-IgG: A multicenter study in South China.J Neuroimmunol. 2018 Aug 15;321:83-91.
7. Cellina M, Fetoni V, Ciocca M, Pirovano M, Oliva G.Anti-myelin oligodendrocyte glycoproteinantibodies: Magnetic resonance imaging findings in a case series and a literature review.Neuroradiol J. 2018 Feb;31(1):69-82.